These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22994851)
1. Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine. Shibata I; Cho S; Yoshitomi O; Ureshino H; Maekawa T; Hara T; Sumikawa K Scand Cardiovasc J Suppl; 2013 Feb; 47(1):50-7. PubMed ID: 22994851 [TBL] [Abstract][Full Text] [Related]
2. Administration of the Rho-kinase inhibitor fasudil before ischemia or just after reperfusion, but not 30 min after reperfusion, protects the stunned myocardium in swine. Shibata I; Yoshitomi O; Use T; Ureshino H; Cho S; Maekawa T; Hara T; Sumikawa K Cardiovasc Drugs Ther; 2008 Aug; 22(4):293-8. PubMed ID: 18470606 [TBL] [Abstract][Full Text] [Related]
3. Milrinone administered before ischemia or just after reperfusion, attenuates myocardial stunning in anesthetized swine. Use T; Makita T; Ureshino H; Cho S; Yoshitomi O; Akiyama D; Oshibuchi M; Hara T; Sumikawa K Cardiovasc Drugs Ther; 2006 Oct; 20(5):327-34. PubMed ID: 17119877 [TBL] [Abstract][Full Text] [Related]
4. Inhalation of hydrogen gas protects against myocardial stunning and infarction in swine. Sakai K; Cho S; Shibata I; Yoshitomi O; Maekawa T; Sumikawa K Scand Cardiovasc J; 2012 Jun; 46(3):183-9. PubMed ID: 22263852 [TBL] [Abstract][Full Text] [Related]
5. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs. Papp JG; Pollesello P; Varró AF; Végh AS J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290 [TBL] [Abstract][Full Text] [Related]
6. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism. Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167 [TBL] [Abstract][Full Text] [Related]
7. Intracoronary levosimendan enhances contractile function of stunned myocardium. Jamali IN; Kersten JR; Pagel PS; Hettrick DA; Warltier DC Anesth Analg; 1997 Jul; 85(1):23-9. PubMed ID: 9212117 [TBL] [Abstract][Full Text] [Related]
8. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model. Metzsch C; Liao Q; Steen S; Algotsson L Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861 [TBL] [Abstract][Full Text] [Related]
9. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model. Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study. Wu X; Wu J; Yan X; Zhang Y Cardiology; 2014; 128(2):202-8. PubMed ID: 24751502 [TBL] [Abstract][Full Text] [Related]
11. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning. Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430 [TBL] [Abstract][Full Text] [Related]
12. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone. Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740 [TBL] [Abstract][Full Text] [Related]
13. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure. Segreti JA; Marsh KC; Polakowski JS; Fryer RM J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907 [TBL] [Abstract][Full Text] [Related]
15. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related]
16. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction. Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242 [TBL] [Abstract][Full Text] [Related]
17. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes. Markou T; Makridou Z; Galatou E; Lazou A Eur J Pharmacol; 2011 Sep; 667(1-3):298-305. PubMed ID: 21664904 [TBL] [Abstract][Full Text] [Related]
18. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [TBL] [Abstract][Full Text] [Related]
19. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Caimmi PP; Molinari C; Uberti F; Micalizzi E; Valente G; Mary DA; Vacca G; Grossini E Eur J Cardiothorac Surg; 2011 Apr; 39(4):e59-67. PubMed ID: 21247774 [TBL] [Abstract][Full Text] [Related]
20. Ca2+ sensitizer superior to catecholamine during myocardial stunning? Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]